Male CNS – Cell Type Explorer


Post
Pre

LA
-
-

ME 1	ME 2	ME 3	ME 4	ME 5	ME 6	ME 7	ME 8	ME 9	ME 10	Total
300	-	-	-	-	-	5	6	-	-	311
137	-	-	-	-	-	1	2	-	-	140


Post
Pre

LO 1	LO 2	LO 3	LO 4	LO 5A	LO 5B	LO 6	Total
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-

AME
1,082
351


Post
Pre

LOP 1	LOP 2	LOP 3	LOP 4	Total
-	-	-	-	-
-	-	-	-	-

central brain
-
-

Neuron Visualization ⧉

Dark Light

ROI Name	∑ In	% In	log ratio	∑ Out	% Out
AME(R)	1,082	69.9%	-1.62	351	68.6%
ME(R)	311	20.1%	-1.15	140	27.3%
Optic-unspecified(R)	155	10.0%	-2.88	21	4.1%

upstream partner	#	NT	conns aMe6c	% In	CV
HBeyelet (R)	3	HA	402	26.4%	0.1
aMe4 (R)	9	ACh	378	24.8%	0.8
MeVPMe12 (L)	2	ACh	173	11.3%	0.1
aMe12 (R)	2	ACh	108	7.1%	0.1
OA-AL2i3 (R)	2	OA	64	4.2%	0.5
MeVCMe1 (R)	2	ACh	63	4.1%	0.1
aMe6b (R)	1	ACh	49	3.2%	0.0
MeVCMe1 (L)	2	ACh	45	3.0%	0.4
Cm35 (R)	1	GABA	34	2.2%	0.0
Dm9 (R)	8	Glu	24	1.6%	0.7
C2 (R)	8	GABA	22	1.4%	0.5
R8y	5	HA	17	1.1%	0.6
aMe1 (R)	2	GABA	16	1.0%	0.1
Tm5c (R)	6	Glu	13	0.9%	0.3
MeVPaMe2 (L)	1	Glu	12	0.8%	0.0
MeVPMe11 (L)	1	Glu	11	0.7%	0.0
R8_unclear	6	HA	10	0.7%	0.9
R7p	4	HA	8	0.5%	0.6
MeVC3 (L)	1	ACh	6	0.4%	0.0
aMe12 (L)	3	ACh	6	0.4%	0.4
Mi1 (R)	1	ACh	5	0.3%	0.0
MeVPMe3 (L)	1	Glu	5	0.3%	0.0
R7_unclear	3	HA	5	0.3%	0.3
l-LNv (R)	3	unc	5	0.3%	0.3
l-LNv (L)	3	unc	4	0.3%	0.4
MeVPaMe1 (R)	1	ACh	3	0.2%	0.0
Cm11a (R)	2	ACh	3	0.2%	0.3
aMe5 (R)	2	ACh	3	0.2%	0.3
Cm20 (R)	1	GABA	2	0.1%	0.0
L1 (R)	1	Glu	2	0.1%	0.0
MeVPMe4 (L)	1	Glu	2	0.1%	0.0
aMe30 (R)	1	Glu	2	0.1%	0.0
R7y	2	HA	2	0.1%	0.0
L3 (R)	2	ACh	2	0.1%	0.0
Mi15 (R)	1	ACh	1	0.1%	0.0
R8p	1	HA	1	0.1%	0.0
MeVP1 (R)	1	ACh	1	0.1%	0.0
Mi13 (R)	1	Glu	1	0.1%	0.0
T2 (R)	1	ACh	1	0.1%	0.0
Tm3 (R)	1	ACh	1	0.1%	0.0
MeLo7 (R)	1	ACh	1	0.1%	0.0
Tm2 (R)	1	ACh	1	0.1%	0.0
aMe2 (R)	1	Glu	1	0.1%	0.0
Mi18 (R)	1	GABA	1	0.1%	0.0
AN09A005 (R)	1	unc	1	0.1%	0.0
Dm20 (R)	1	Glu	1	0.1%	0.0
MeVP63 (R)	1	GABA	1	0.1%	0.0
MeVP48 (R)	1	Glu	1	0.1%	0.0
Mi19 (R)	1	unc	1	0.1%	0.0
PLP211 (R)	1	unc	1	0.1%	0.0
MeVC22 (R)	1	Glu	1	0.1%	0.0
MeVC23 (R)	1	Glu	1	0.1%	0.0
MeVPMe12 (R)	1	ACh	1	0.1%	0.0

downstream partner	#	NT	conns aMe6c	% Out	CV
aMe6b (R)	1	ACh	267	17.8%	0.0
MeVPMe12 (L)	2	ACh	237	15.8%	0.3
aMe1 (R)	2	GABA	162	10.8%	0.1
Lawf1 (R)	17	ACh	132	8.8%	0.9
aMe10 (R)	2	ACh	94	6.3%	0.2
aMe4 (R)	9	ACh	88	5.9%	0.4
aMe17b (R)	2	GABA	63	4.2%	0.2
MeVPMe12 (R)	2	ACh	62	4.1%	0.4
aMe15 (R)	1	ACh	58	3.9%	0.0
aMe5 (R)	10	ACh	52	3.5%	0.9
Tm3 (R)	12	ACh	34	2.3%	1.0
Mi18 (R)	5	GABA	33	2.2%	0.8
Tm5c (R)	11	Glu	19	1.3%	0.6
TmY10 (R)	6	ACh	17	1.1%	0.8
T2 (R)	6	ACh	16	1.1%	0.6
OA-AL2i3 (R)	2	OA	12	0.8%	0.0
MeVPaMe2 (R)	1	Glu	11	0.7%	0.0
l-LNv (R)	4	unc	11	0.7%	0.7
MeVP29 (R)	1	ACh	10	0.7%	0.0
Cm35 (R)	1	GABA	10	0.7%	0.0
Mi10 (R)	5	ACh	9	0.6%	0.6
HBeyelet (R)	3	HA	8	0.5%	0.5
aMe12 (R)	2	ACh	8	0.5%	0.0
Dm10 (R)	4	GABA	7	0.5%	0.5
TmY18 (R)	1	ACh	6	0.4%	0.0
C3 (R)	4	GABA	6	0.4%	0.3
aMe6a (R)	1	ACh	5	0.3%	0.0
TmY3 (R)	2	ACh	4	0.3%	0.5
Mi15 (R)	3	ACh	4	0.3%	0.4
Dm9 (R)	3	Glu	4	0.3%	0.4
aMe30 (R)	2	Glu	4	0.3%	0.0
aMe3 (R)	1	Glu	3	0.2%	0.0
Cm2 (R)	1	ACh	2	0.1%	0.0
Mi2 (R)	1	Glu	2	0.1%	0.0
Tm5Y (R)	1	ACh	2	0.1%	0.0
Mi1 (R)	1	ACh	2	0.1%	0.0
Cm11d (R)	1	ACh	2	0.1%	0.0
aMe_TBD1 (R)	1	GABA	2	0.1%	0.0
MeVPMe13 (R)	1	ACh	2	0.1%	0.0
Tm4 (R)	2	ACh	2	0.1%	0.0
MeLo2 (R)	2	ACh	2	0.1%	0.0
CL125 (R)	2	Glu	2	0.1%	0.0
MeVCMe1 (R)	2	ACh	2	0.1%	0.0
Cm1 (R)	1	ACh	1	0.1%	0.0
Tm20 (R)	1	ACh	1	0.1%	0.0
aMe2 (R)	1	Glu	1	0.1%	0.0
Tm5b (R)	1	ACh	1	0.1%	0.0
Tm12 (R)	1	ACh	1	0.1%	0.0
TmY5a (R)	1	Glu	1	0.1%	0.0
Mi4 (R)	1	GABA	1	0.1%	0.0
MeVP1 (R)	1	ACh	1	0.1%	0.0
Tm16 (R)	1	ACh	1	0.1%	0.0
Lat1 (R)	1	unc	1	0.1%	0.0
Lawf2 (R)	1	ACh	1	0.1%	0.0
L1 (R)	1	Glu	1	0.1%	0.0
Cm24 (R)	1	Glu	1	0.1%	0.0
Lat5 (R)	1	unc	1	0.1%	0.0
MeVP63 (R)	1	GABA	1	0.1%	0.0
aMe26 (R)	1	ACh	1	0.1%	0.0
Cm28 (R)	1	Glu	1	0.1%	0.0
MeVC20 (R)	1	Glu	1	0.1%	0.0
aMe12 (L)	1	ACh	1	0.1%	0.0
5thsLNv_LNd6 (R)	1	ACh	1	0.1%	0.0
MeVPMe11 (L)	1	Glu	1	0.1%	0.0
MeVCMe1 (L)	1	ACh	1	0.1%	0.0